Welcome to this UK AstraZeneca produced and funded website

This website is intended for UK Healthcare professionals only.

 

The website contains both promotional and non-promotional content.

 

If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk

 

For any other UK residents please visit astrazeneca.co.uk

I am not a Healthcare Professional
Prescribing Information Forxiga® (dapagliflozin)
Adverse Event Reporting

This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk

Logo test product
  • Products
    • FORXIGA® (dapagliflozin)
    • LOKELMA® (sodium zirconium cyclosilicate)
    • LYNPARZA® (olaparib)
    • IMFINZI® (durvalumab)
    • IMJUDO®▼ (tremelimumab)
    • SYMBICORT® (budesonide/formoterol)
    • TEZSPIRE®▼ (tezepelumab)
    • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
    • BEVESPI AEROSPHERE® (glycopyrronium/formoterol)
    • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
  • Therapeutic Areas
    • Cardiovascular
    • Metabolic
    • Renal
    • Respiratory
  • About us
    • AZ Commitment
  • Contact us
Login
  • AstraZeneca UK
  • Forxiga (dapagliflozin)
  • Resources
  • Welcome to Forxiga
  • Type 2 Diabetes
  • Chronic Kidney Disease
  • Heart Failure
  • Safety
  • Clinical and Prescribing Details
    Prescribing Dapagliflozin Forxiga’s Mode of Action
  • Resources
    All Resources Patient Resources Dapa-id

Welcome to Forxiga Type 2 Diabetes Chronic Kidney Disease Heart FailureSafety

Prescribing Dapagliflozin Forxiga’s Mode of Action

All Resources Patient Resources Dapa-id

Resources

Explore informative videos and guides for both prescribers and patients to help you understand more about FORXIGA (dapagliflozin)



Dapagliflozin is indicated for the treatment of insufficiently controlled T2D, CKD, and symptomatic chronic HF1

Explore our informative videos and printable guides to help you understand more about dapagliflozin

Here you can access educational materials and videos to watch at your convenience.

These videos and resources have been developed and funded by AstraZeneca and contain mentioning of AstraZeneca’s products.

Challenging the status quo in CKD management

Watch Dr Will Hinchliffe discuss the current landscape of chronic kidney disease management and the need to optimise treatment at the earliest opportunity.

Watch the video

A straightforward film about QRISK2 and T2DM

Watch this short animation to learn about how many people in the UK are eligible for an SGLT2i according to NICE and how many patients are still not being considered for an SGLT2i.

Watch the video

Protecting cardiorenal function in patients with T2DM: understanding the practicalities of treatment

Watch Advanced Nurse Practitioner and Diabetes Specialist Nurse Judy Winter discuss how to protect cardiorenal function in patients with type 2 diabetes.

Watch the video

Tick tock, slow the eGFR clock: managing kidney risk in people with T2DM

Watch Advanced Nurse Practitioner and Diabetes Specialist Nurse Judy Winter discuss managing kidney risk and slowing eGFR decline in patients with type 2 diabetes.

Watch the video

Understanding the benefit of holistic care in T2DM

Watch Advanced Nurse Practitioner Beverley Bostock discuss the benefits of holistic care in type 2 diabetes.

Watch the video

The evolution in heart failure management

Watch Professor Roy Gardner discuss the evolution of heart failure management.

Watch the video

Dr Yassir Javaid: NG28 Guidelines and Type 2 Diabetes: Reducing Cardiorenal Risk in our Patients

Watch Dr Yassir Javaid discuss the NICE guidance on the management of type 2 diabetes and how this should impact clinical practice in primary care.

Watch the video

Dr Yassir Javaid: Type 2 Diabetes and Declining Renal Function - It’s time to act

Watch Dr Yassir Javaid discuss the NICE Type 2 Diabetes Guidance and evidence for managing patients with T2D and declining renal function.

Watch the video

Professor James Burton: Michael's Story - early intervention to prevent CKD progression in T2D

Watch Professor James Burton discuss the hypothetical case study of Michael, a patient living with type 2 diabetes and a declining eGFR.

Watch the video

Professor James Burton: Chronic Kidney Disease Treatment Beyond Diabetes

Watch Professor James Burton discuss the DAPA-CKD study, and the use of dapagliflozin in patients with chronic kidney disease, without type 2 diabetes.

Watch the video

Professor Vinod Patel: Cardiorenal disease in type 2 diabetes: a paradigm shift in management

Watch Professor Vinod Patel discuss the NICE Type 2 Diabetes Guidance and explore how dapagliflozin could be a suitable option for people living with type 2 diabetes.

Watch the video

Professor Pardeep Jhund: Simplifying the management of heart failure across the ejection fraction: DELIVER data and pooled analysis

Watch Professor Pardeep Jhund discuss the DELIVER study, and the use of dapagliflozin in heart failure with reduced ejection fraction.

Watch the video

The interplay of CVRM systems

A 3-minute animation exploring the interplay and outcomes of cardiovascular, renal, and metabolic (CVRM) disease

Watch the video

Impact of not treating renal complications of T2D

A 90 second animation looking at the impact on patients and the healthcare system of the renal complications of type-2 diabetes

Watch the video

Dr Lavan Baskaran: Managing the multimorbid patient with renal disease

Watch Dr Lavan Baskaran discuss his proactive approach to identifying and optimising patients living with type 2 diabetes and a declining eGFR.

Watch the video

Dapagliflozin Initiation Checklist

This checklist has been designed to aid your patient consultations following your decision to prescribe Forxiga.

Download

Implementing risk-based care in type 2 diabetes

Watch Niraj Lakhani share an example of changing practice to deliver proactive, guideline-directed care in his PCN for people living with type 2 diabetes and cardiorenal disease.

Watch the video

See beyond sugar: Uncovering risk in type 2 diabetes

Watch Naresh Kanumilli discuss the importance of looking beyond glucose in type 2 diabetes management, by considering cardiorenal risk.

Watch the video

Explore the NICE T2DM guideline: A risk-based approach to T2DM care

A digital infographic on the NICE type 2 diabetes guidelines to support healthcare professionals in their treatment decisions.

Download

Applying the NICE T2DM guideline in clinical practice

A digital resource with practical guidance to support you in taking a risk-based approach in the management of your T2DM patients.

Download

Animated patient information resource

This patient leaflet contains a QR code for patients to learn more about their medication and includes a short video about FORXIGA available in 10 languages: English, Welsh, Bengali, Gujarati, Punjabi, Nepalese, Somali, Urdu, Polish and Romanian.

Download this resource

Guide to FORXIGA: Heart Failure

A quick guide that introduces your patients to FORXIGA and helps them to better understand heart failure

Download the HF with T2D resource Download the HF without T2D resource

Guide to FORXIGA: Chronic Kidney Disease

A quick guide that introduces your patients to FORXIGA and helps them to manage their chronic kidney disease

Download the CKD with T2D resource Download the CKD without T2D resource

Guide to FORXIGA: Type 2 Diabetes

A short booklet introducing FORXIGA and helping patients to understand and manage their type 2 diabetes

Download this resource

Sick day rules leaflet

A short leaflet to support patients manage their treatment during an illness. Available for patients with type 2 diabetes, or for those with chronic kidney disease or heart failure.

Download the T2D resource Download the CKD or HF resource

If you wish to order hard copy materials, please submit the form below:
Fields marked with * are mandatory
Note: Your personal details will not be used for any promotional purposes without your explicit consent.
More details can be found in our Privacy Policy.

Form Loading...

Thank you for your submission!

Your request is being processed; the items selected will be delivered as soon as possible.
Please make sure the delivery point is expecting your support materials.



Should you have any questions, check contact us.

  1. FORXIGA 10 mg film-coated tablets - Summary of Product Characteristics (SmPC).

GB-59465 | DOP: November 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling ‌‌‌0‌‌‌8‌‌‌‌‌0‌‌‌‌0‌‌‌ ‌‌7‌‌‌‌‌‌8‌‌‌3‌‌‌ ‌‌0‌‌‌‌‌0‌‌‌‌3‌‌‌‌3‌‌‌.

Connessiallasalute.it

This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.

Terms of use

Privacy Policy

Cookie Policy

Contact Us

LinkedIn

Twitter

©2024 AstraZeneca. GB-63906 | DOP: February 2025